Cargando…
Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project
BACKGROUND: Small-scale studies suggest that hyperkalaemia is a less threatening condition in chronic kidney disease (CKD), arguing adaptation/tolerance to potassium (K(+)) retention. This study formally evaluates this hypothesis by estimating the distribution of plasma K(+) and its association with...
Autores principales: | Gasparini, Alessandro, Evans, Marie, Barany, Peter, Xu, Hairong, Jernberg, Tomas, Ärnlöv, Johan, Lund, Lars H, Carrero, Juan-Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735645/ https://www.ncbi.nlm.nih.gov/pubmed/30085251 http://dx.doi.org/10.1093/ndt/gfy249 |
Ejemplares similares
-
The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
por: Runesson, Björn, et al.
Publicado: (2016) -
Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
por: Bandak, Ghassan, et al.
Publicado: (2017) -
Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project
por: Runesson, Björn, et al.
Publicado: (2019) -
Albuminuria and the risk of cancer: the Stockholm CREAtinine Measurements (SCREAM) project
por: Luo, Li, et al.
Publicado: (2023) -
Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
por: Alkas, Jim, et al.
Publicado: (2022)